BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20818438)

  • 1. Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.
    Dwyer J; Le Guelte A; Galan Moya EM; Sumbal M; Carlotti A; Douguet L; Gutkind JS; Grange PA; Dupin N; Gavard J
    Oncogene; 2011 Jan; 30(2):190-200. PubMed ID: 20818438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
    Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
    Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
    Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
    Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia.
    Montaner S; Sodhi A; Servitja JM; Ramsdell AK; Barac A; Sawai ET; Gutkind JS
    Blood; 2004 Nov; 104(9):2903-11. PubMed ID: 15231571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different PI 3-kinase inhibitors have distinct effects on endothelial permeability and leukocyte transmigration.
    Cain RJ; Vanhaesebroeck B; Ridley AJ
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1929-36. PubMed ID: 22814170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat.
    Pati S; Foulke JS; Barabitskaya O; Kim J; Nair BC; Hone D; Smart J; Feldman RA; Reitz M
    J Virol; 2003 May; 77(10):5759-73. PubMed ID: 12719569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.
    Sodhi A; Montaner S; Patel V; Gómez-Román JJ; Li Y; Sausville EA; Sawai ET; Gutkind JS
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4821-6. PubMed ID: 15047889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.
    Yang TY; Chen SC; Leach MW; Manfra D; Homey B; Wiekowski M; Sullivan L; Jenh CH; Narula SK; Chensue SW; Lira SA
    J Exp Med; 2000 Feb; 191(3):445-54. PubMed ID: 10662790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice.
    Thirunarayanan N; Cifire F; Fichtner I; Posner S; Benga J; Reiterer P; Kremmer E; Kölble K; Lipp M
    Oncogene; 2007 Aug; 26(39):5702-12. PubMed ID: 17353903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.
    Guo HG; Pati S; Sadowska M; Charurat M; Reitz M
    J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity.
    Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H
    Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin.
    Qian LW; Greene W; Ye F; Gao SJ
    J Virol; 2008 Dec; 82(23):11902-12. PubMed ID: 18815301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
    Martin D; Nguyen Q; Molinolo A; Gutkind JS
    Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
    Sodhi A; Montaner S; Gutkind JS
    FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial PI 3-kinase activity regulates lymphocyte diapedesis.
    Nakhaei-Nejad M; Hussain AM; Zhang QX; Murray AG
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3608-16. PubMed ID: 17890432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma.
    Jensen KK; Manfra DJ; Grisotto MG; Martin AP; Vassileva G; Kelley K; Schwartz TW; Lira SA
    J Immunol; 2005 Mar; 174(6):3686-94. PubMed ID: 15749907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions.
    Azzi S; Smith SS; Dwyer J; Leclair HM; Alexia C; Hebda JK; Dupin N; Bidère N; Gavard J
    Oncogene; 2014 Dec; 33(49):5609-18. PubMed ID: 24292677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.